Chemoinformatic Analysis of GRAS (Generally Recognized as Safe) Flavor Chemicals and Natural Products

Food materials designated as “Generally Recognized as Safe” (GRAS) are attracting the attention of researchers in their attempts to systematically identify compounds with putative health-related benefits. In particular, there is currently a great deal of interest in exploring possible secondary benefits of flavor ingredients, such as those relating to health and wellness. One step in this direction is the comprehensive characterization of the chemical structures contained in databases of flavoring substances. Herein, we report a comprehensive analysis of the recently updated FEMA GRAS list of flavoring substances (discrete chemical entities only). Databases of natural products, approved drugs and a large set of commercial molecules were used as references. Remarkably, natural products continue to be an important source of bioactive compounds for drug discovery and nutraceutical purposes. The comparison of five collections of compounds of interest was performed using molecular properties, rings, atom counts and structural fingerprints. It was found that the molecular size of the GRAS flavoring substances is, in general, smaller cf. members of the other databases analyzed. The lipophilicity profile of the GRAS database, a key property to predict human bioavailability, is similar to approved drugs. Several GRAS chemicals overlap to a broad region of the property space occupied by drugs. The GRAS list analyzed in this work has high structural diversity, comparable to approved drugs, natural products and libraries of screening compounds. This study represents one step towards the use of the distinctive features of the flavoring chemicals contained in the GRAS list and natural products to systematically search for compounds with potential health-related benefits.

[1]  J. Medina-Franco,et al.  Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach , 2010, Molecular Diversity.

[2]  F. Salemme,et al.  A comparison of the chemical properties of drugs and FEMA/FDA notified GRAS chemical compounds used in the food industry. , 2007, Food and Chemical Toxicology.

[3]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[4]  Dragos Horvath,et al.  Using self-organizing maps to accelerate similarity search. , 2012, Bioorganic & medicinal chemistry.

[5]  Sivaraman Dandapani,et al.  Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. , 2010, Nature chemical biology.

[6]  Masanori Arita,et al.  Databases on food phytochemicals and their health-promoting effects. , 2011, Journal of agricultural and food chemistry.

[7]  Yoo Jakyung,et al.  Chemoinformatic Approaches for Inhibitors of DNA Methyltransferases: Comprehensive Characterization of Screening Libraries , 2011 .

[8]  I. Carabin,et al.  Generally recognized as safe (GRAS): history and description. , 2004, Toxicology letters.

[9]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[10]  M Berrie.  Division of chemical information. , 2000, IDrugs : the investigational drugs journal.

[11]  Stuart L. Schreiber,et al.  Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections , 2011, Proceedings of the National Academy of Sciences.

[12]  Dimitris K. Agrafiotis,et al.  A Constant Time Algorithm for Estimating the Diversity of Large Chemical Libraries , 2001, J. Chem. Inf. Comput. Sci..

[13]  José L. Medina-Franco,et al.  Increased Diversity of Libraries from Libraries: Chemoinformatic Analysis of Bis‐Diazacyclic Libraries , 2011, Chemical biology & drug design.

[14]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[15]  Woody Sherman,et al.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods , 2010, J. Cheminformatics.

[16]  Alan L Harvey,et al.  Current strategies for drug discovery through natural products , 2010, Expert opinion on drug discovery.

[17]  P. Jaccard,et al.  Etude comparative de la distribution florale dans une portion des Alpes et des Jura , 1901 .

[18]  James C Griffiths,et al.  The importance of GRAS to the functional food and nutraceutical industries. , 2006, Toxicology.

[19]  G. Burdock.  The GRAS Process Regulatory Impact , 2003 .

[20]  J. Medina-Franco,et al.  Foodinformatics: Applications of Chemical Information to Food Chemistry , 2014 .

[21]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[22]  Fabian López-Vallejo,et al.  Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. , 2011, Combinatorial chemistry & high throughput screening.

[23]  José L. Medina-Franco,et al.  Interrogating Novel Areas of Chemical Space for Drug Discovery using Chemoinformatics , 2012 .

[24]  Jaime Pérez-Villanueva,et al.  Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. , 2010, Bioorganic & medicinal chemistry.

[25]  Robert L. Smith,et al.  GRAS flavoring substances 25 , 2001 .

[26]  Austin B. Yongye,et al.  Characterization of a comprehensive flavor database , 2011 .

[27]  Alberto Del Rio,et al.  Freely accessible databases of commercial compounds for high- throughput virtual screenings. , 2012, Current topics in medicinal chemistry.

[28]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[29]  Peter Ertl,et al.  Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries , 2008, J. Chem. Inf. Model..

[30]  J. Medina-Franco,et al.  Expanding the medicinally relevant chemical space with compound libraries. , 2012, Drug discovery today.

[31]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[32]  José L Medina-Franco,et al.  Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.

[33]  Stephen D Pickett,et al.  The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. , 2011, Drug discovery today.

[34]  Didier Rognan,et al.  Structure‐Based Approaches to Target Fishing and Ligand Profiling , 2010, Molecular informatics.

[35]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[36]  José L Medina-Franco,et al.  Computational methods for the discovery of mood disorder therapies , 2011, Expert opinion on drug discovery.

[37]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[38]  Giuseppe Felice Mangiatordi,et al.  CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes. , 2010, Molecular bioSystems.

[39]  José L. Medina-Franco,et al.  Visualization of the Chemical Space in Drug Discovery , 2008 .

[40]  Jacob de Vlieg,et al.  Comparative Analysis of Pharmacophore Screening Tools , 2012, J. Chem. Inf. Model..

[41]  Stefan Wetzel,et al.  Charting, navigating, and populating natural product chemical space for drug discovery. , 2012, Journal of medicinal chemistry.

[42]  G. V. Paolini,et al.  Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.

[43]  Giulio Rastelli,et al.  Structure-based design of potent aromatase inhibitors by high-throughput docking. , 2011, Journal of medicinal chemistry.

[44]  Thomas Henkel,et al.  Statistical Investigation into the Structural Complementarity of Natural Products and Synthetic Compounds. , 1999, Angewandte Chemie.

[45]  Alberto Del Rio,et al.  Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives , 2012, Current pharmaceutical design.

[46]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..

[47]  Miklos Feher,et al.  Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..